ArticleJuntendo medical journal2026
Suspected Cannabinoid Hyperemesis Syndrome in a Traveler from a Cannabis-Legal Country: A Case Report from Japan.
Article in Juntendo medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cannabinoid hyperemesis syndrome (CHS) is characterized by recurrent nausea, vomiting, and abdominal pain in chronic cannabis users. We report a case of suspected CHS in a 37-year-old Canadian male who presented to a Japanese emergency department (ED) with severe abdominal pain and persistent vomiting. He reported chronic cannabis use two to four times per week for several years, with the last use the day before departure from Canada. Urine drug screening was positive for tetrahydrocannabinol. Although the clinical presentation was consistent with the hyperemetic phase of CHS, a definitive diagnosis could not be established due to the single-visit nature of the encounter and incomplete acquisition of key diagnostic information. This case highlights the diagnostic challenges of CHS in foreign travelers presenting to EDs in cannabis-prohibited countries, where linguistic, cultural, and legal barriers may impede timely recognition. Early consideration of CHS and systematic history-taking are essential to avoid diagnostic delays in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.